Company Johnson & Johnson

Equities

JNJ

US4781601046

Pharmaceuticals

Market Closed - Nyse 04:00:02 2024-03-18 pm EDT Pre-market 07:00:08 am
156.8 USD -0.90% Intraday chart for Johnson & Johnson 156.9 +0.10%

Business Summary

Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows:

- pharmaceutical products (55.4%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, gastro-intestinal illnesses, infectious, immunological, neurological, dermatological diseases, etc.;

- medical products and equipment (28.9%): diagnostic systems, orthopedic and gynecological equipment, surgical materials, etc. for use by healthcare professionals;

- consumer health products (15.7%): OTC drugs (Tylenol, Sudafed, Benadryl, Zyrtec, Motrin, Nicorette and other brands), health and beauty products (Aveeno, Clean & Clear, Dr. CI:Labo, Neutrogena and OGX), baby care products (Johnson's and Aveeno Baby), oral care products (Listerine), feminine hygiene products (Stayfree and Carefree and o.b.), wound care products (Band-Aid and Neosporin) etc.

At the end of 2022, Johnson & Johnson has 89 manufacturing facilities located in the United States (28), North America (9), Europe (27), Africa and Asia/Pacific (25).

Net sales are distributed geographically as follows: the United States (51.2%), Europe (24.7%), Asia/Pacific and Africa (17.7%) and other (6.4%).

Number of employees: 131,900

Sales per Business

USD in Million2022Weight2023Weight Delta
Innovative Medicine
64.3 %
52,563 55.4 % 54,759 64.3 % +4.18%
MedTech
35.7 %
27,427 28.9 % 30,400 35.7 % +10.84%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
54.5 %
48,580 51.2 % 46,444 54.5 % -4.40%
Europe
24.0 %
23,449 24.7 % 20,410 24.0 % -12.96%
Asia-Pacific, Africa
16.2 %
16,789 17.7 % 13,756 16.2 % -18.07%
Western Hemisphere Excluding United States
5.3 %
6,125 6.5 % 4,549 5.3 % -25.73%

Managers

Managers TitleAgeSince
Chief Executive Officer 61 88-12-31
Director of Finance/CFO 57 97-12-31
Chief Tech/Sci/R&D Officer 58 19-11-04
Chief Tech/Sci/R&D Officer - 22-12-30
Chief Tech/Sci/R&D Officer 74 06-12-31
Investor Relations Contact - 21-10-31
Corporate Officer/Principal - -
Corporate Officer/Principal - -
Corporate Officer/Principal - -
Corporate Officer/Principal 47 18-12-31

Members of the board

Members of the board TitleAgeSince
Director/Board Member 70 19-04-24
Director/Board Member 72 14-06-18
Director/Board Member 70 09-10-21
Director/Board Member 64 19-12-04
Director/Board Member 60 13-10-14
Chief Executive Officer 61 88-12-31
Director/Board Member 58 22-02-14
Director/Board Member 59 Nov. 29
Director/Board Member 62 19-12-04
Director/Board Member 62 20-12-02

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 3,121,532,228 2,404,690,278 ( 77.04 %) 712,765,000 ( 22.83 %) 77.04 %

Shareholders

NameEquities%Valuation
Vanguard Fiduciary Trust Co.
9.523 %
229,387,671 9.523 % 37 019 M $
BlackRock Advisors LLC
5.999 %
144,513,971 5.999 % 23 322 M $
132,904,295 5.518 % 21 448 M $
Geode Capital Management LLC
2.128 %
51,256,785 2.128 % 8 272 M $
Eaton Vance Management
1.729 %
41,659,479 1.729 % 6 723 M $
BlackRock Life Ltd.
1.471 %
35,434,128 1.471 % 5 718 M $
State Farm Investment Management Corp.
1.315 %
31,675,492 1.315 % 5 112 M $
JPMorgan Investment Management, Inc.
1.207 %
29,075,605 1.207 % 4 692 M $
Capital Research & Management Co. (International Investors)
1.203 %
28,985,676 1.203 % 4 678 M $
Wells Fargo Bank NA
1.100 %
26,495,671 1.100 % 4 276 M $
NameEquities%Valuation
BB Gestão de Recursos DTVM SA
0.000731 %
264,349 0.000731 % 3 M $
Itaú Unibanco SA
0.000491 %
177,564 0.000491 % 2 M $
Safra Asset Management Ltda.
0.000262 %
94,900 0.000262 % 1 M $
Bram Bradesco Asset Management S/A DTVM
0.000251 %
90,820 0.000251 % 978 454 $
Caixa DTVM SA
0.000115 %
41,422 0.000115 % 446 262 $
XP Allocation Asset Management Ltda.
0.000038 %
13,915 0.000038 % 149 914 $
Warren Brasil Gestão e Administração e Recursos Ltda.
0.000024 %
8,663 0.000024 % 93 331 $
Western Asset Management Company DTVM Ltda.
0.000008 %
3,024 0.000008 % 32 579 $
Morgan Stanley Administradora de Carteiras SA
0.000000 %
51 0.000000 % 549 $

Holdings

NameEquities%Valuation
182,329,550 9.52% 3,464,261,450 $
810,170 0.51% 113,286,071 $
2,449,183 4.20% 74,406,180 $
3,495,575 16.70% 68,618,137 $
814,586 0.56% 53,078,424 $
3,670,516 5.07% 43,899,371 $
166,812 0.45% 43,516,246 $
6,641,064 10.44% 40,975,365 $
5,623,816 11.93% 35,148,850 $
1,849,445 1.21% 32,605,715 $

Company contact information

Johnson & Johnson

One Johnson & Johnson Plaza

08933, New Brunswick

+732 524 0400

http://www.jnj.com
address Johnson & Johnson(JNJ)

Group companies

NameCategory and Sector
Medical Specialties
Pharmaceuticals: Major
Electronic Components
Medical Specialties
Pharmaceuticals: Major
Pharmaceuticals: Major
Household/Personal Care
Pharmaceuticals: Major
Medical Specialties

Sales per Business

Sales per region

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
23
Last Close Price
156.8 USD
Average target price
174.4 USD
Spread / Average Target
+11.26%
Consensus